Does TOFACITINIB Cause Dysgraphia? 185 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 185 reports of Dysgraphia have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
185
Reports of Dysgraphia with TOFACITINIB
0.1%
of all TOFACITINIB reports
7
Deaths
34
Hospitalizations
How Dangerous Is Dysgraphia From TOFACITINIB?
Of the 185 reports, 7 (3.8%) resulted in death, 34 (18.4%) required hospitalization.
Is Dysgraphia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 185 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Dysgraphia?
DIMETHYL (238)
PREGABALIN (233)
DALFAMPRIDINE (226)
FINGOLIMOD (222)
VALPROATE (199)
INTERFERON BETA-1A (191)
NATALIZUMAB (171)
PIMAVANSERIN (161)
TERIFLUNOMIDE (141)
CARBIDOPA\LEVODOPA (122)
Which TOFACITINIB Alternatives Have Lower Dysgraphia Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN